| BCG | bacille Calmette-Guerin [vaccine]; ballistocardiography, ballistocardiogram; bicolor guaiac test; br... |
|---|---|
| DEV | deviant, deviation; duck embryo vaccine or virus |
| DPT | Demerol, Phenergan, and Thorazine; dermatopontin; dichotic pitch discrimination test; diphtheria-per... |
| DPTPM | diphtheria-pertussis-tetanus-poliomyelitis-measles [vaccine] |
| DTaP | diphtheria-tetanus-pertussis [vaccine] |
| influenza viruses | Virus's of the family Orthomyxoviridae which cause influenza and influenza-like infections of humans and other animals; virus's included are influenza virus types A and B of the genus Influenzavirus, causing, respectively, influenza A and B, and influenza virus type C, which probably belongs to a separate genus and causes influenza C. (05 Mar 2000) |
|---|---|
| influenza virus vaccines | Influenza virus grown in embryonated eggs and inactivated, usually by the addition of formalin; both whole virus and subunit preparations containing haemagglutinins and neuraminidase are used; because of the marked and progressive antigenic variation of the influenza viruses, the strains included are regularly changed following various outbreaks of influenza in order to include most recently isolated epidemic strains of both type A influenza and type B influenza. (05 Mar 2000) |
| endemic influenza | Influenza, usually of a less severe type, occurring with some degree of regularity during the winter season, especially in the larger cities of the world. Synonym: influenza nostras. (05 Mar 2000) |
| equine influenza | <veterinary, virology> A highly contagious upper respiratory infection of horses and other equids caused by equine strains of influenza virus type A. It is characterised by fever and respiratory signs similar to but more severe than those of equine rhinopneumonitis; oedema of the lower trunk and limbs (epizootic cellulitis) may occur; the disease is frequently fatal when secondary bacterial pneumonia intervenes. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| brucella strain 19 vaccine | A live bacterial vaccine prepared from an attenuated variant strain of Brucella abortus (strain 19); used for vaccinating cattle against brucellosis. (05 Mar 2000) |
| brucella vaccine | A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats. (12 Dec 1998) |
| Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| rabies vaccine | An inactivated virus vaccine, used for preexposure immunization to persons at high risk of exposure, e.g., veterinarians, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. The official preparation is human diploid cell vaccine produced from rabies virus grown in cultures of human diploid embryo lung cells and inactivated with propriolactone. It has a much lower incidence of adverse reactions than the previously used duck embryo vaccine. (12 Dec 1998) |